![]() |
市场调查报告书
商品编码
1780231
组织库市场规模、份额、成长分析(按产品、组织类型、应用、最终用户和地区)- 产业预测,2025 年至 2032 年Tissue Banking Market Size, Share, and Growth Analysis, By Product (Equipment, Cryopreservation Equipment), By Tissue Type (Heart Valves, Cornea), By Application, By End-User, By Region - Industry Forecast 2025-2032 |
2023 年全球组织库市场规模价值 43 亿美元,预计将从 2024 年的 45.3 亿美元成长到 2032 年的 68.4 亿美元,预测期间(2025-2032 年)的复合年增长率为 5.3%。
全球组织库市场正经历强劲成长,这得益于再生医学需求的不断增长、慢性疾病患者数量的不断增加以及组织保存技术的不断进步。老年人口的不断增长和组织捐赠意识的不断提升,对市场扩张做出了巨大贡献。此外,政府在医疗基础设施方面的措施和投资,正在支持世界各地现代生物库设施的发展。北美目前凭藉其较高的采用率和良好的法律规范占据市场主导地位,而亚太地区则在医疗支出增长和捐赠者意识提升项目的推动下,正逐渐成为一个有利的市场。
Global Tissue Banking Market size was valued at USD 4.3 Billion in 2023 poised to grow from USD 4.53 Billion in 2024 to USD 6.84 Billion by 2032, growing at a CAGR of 5.3% in the forecast period (2025-2032).
The Global Tissue Banking Market is experiencing robust growth, driven by increasing demand for regenerative medicine, rising cases of chronic diseases, and advancements in tissue preservation technologies. The expanding geriatric population and growing awareness about tissue donation are significantly contributing to market expansion. Additionally, government initiatives and investments in healthcare infrastructure are supporting the development of modern biobanking facilities worldwide. North America currently dominates the market due to high adoption rates and favorable regulatory frameworks, while Asia-Pacific is emerging as a lucrative region, fueled by rising healthcare spending and improved donor awareness programs.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Tissue Banking Market Segments Analysis
The global tissue banking market is segmented based on application, tissue bank, end use, and region. In terms of application, the market is grouped into regenerative medicine, drug discovery, tissue engineering, and transplantation. Based on the tissue bank, the market is trifurcated into cell bank, organ bank, and tissue bank. Based on end use, the market is segmented into hospitals, research institutions, and pharmaceutical companies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.
Driver of the Global Tissue Banking Market
A prominent catalyst for the expansion of the global tissue banking market is the increasing need for regenerative medicine. The growing interest in stem cell therapies, tissue transplants, and customized treatments has led to a heightened demand for essential biological materials stored in tissue banks. This surge in demand is driving advancements in tissue preservation technologies and the development of biobanking infrastructures around the world. As healthcare continues to evolve towards more innovative and personalized approaches, the role of tissue banking becomes increasingly vital, facilitating the availability of crucial resources for researchers and clinicians alike.
Restraints in the Global Tissue Banking Market
The expansion of the global tissue banking market faces significant challenges due to ethical and legal issues related to tissue donation, consent, and privacy. The presence of strict regulations and diverse laws across different regions complicates the processes of tissue collection and utilization. This complexity poses difficulties for tissue banks in implementing uniform practices, as they must navigate and comply with local ethical requirements. Consequently, these constraints can limit the availability of tissues for research and therapeutic applications, ultimately hindering the growth and development of this vital sector in healthcare. Maintaining a balance between ethical considerations and operational efficiency remains a critical concern.
Market Trends of the Global Tissue Banking Market
The global tissue banking market is experiencing a notable trend characterized by the increased adoption of automated biobanking systems. This shift towards automation enhances operational efficiency and significantly minimizes human error, resulting in higher preservation quality of biological samples. As institutions strive for innovation and streamlined processes, advanced technologies such as automated tissue collection, storage, and analysis systems are becoming integral to tissue banking operations. This trend not only boosts the reliability of sample handling but also meets the growing demand from research and clinical applications, ultimately contributing to the market's expansion and evolving landscape as stakeholders prioritize precision and efficiency in tissue preservation.